PhaseRx, Inc.
PZRXQ · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $9,586 | $10,989 | $17,886 | $18,120 |
| - Cash | $5,257 | $4,941 | $6,688 | $9,983 |
| + Debt | $5,441 | $5,887 | $5,795 | $5,703 |
| Enterprise Value | $9,770 | $11,935 | $16,993 | $13,840 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,499 | -$3,277 | -$3,869 | -$3,220 |
| % Margin | – | – | – | – |
| Net Income | -$2,750 | -$3,539 | -$4,125 | -$3,477 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.3 | -0.35 | -0.3 |
| % Growth | 20% | 14.3% | -16.7% | – |
| Operating Cash Flow | -$2,572 | -$3,489 | -$3,626 | -$3,134 |
| Capital Expenditures | $0 | $0 | $0 | -$14 |
| Free Cash Flow | -$2,572 | -$3,489 | -$3,626 | -$3,148 |